OCUGEN, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period
OCUGEN, INC. (OCGN) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period of 332.76 thousand shares for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-08.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod · last filed 2026-05-08
- OCUGEN, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2026-03-31 was 332.76K shares, a 313.68% increase year-over-year.
- OCUGEN, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2025-03-31 was 80.44K shares.
- OCUGEN, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2019-06-30 was 1.41M shares.
- OCUGEN, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2019-03-31 was 1.54M shares, a 124196.44% increase year-over-year.
- OCUGEN, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2025 was 1.26M shares.
- OCUGEN, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2018 was 3.13M shares, a 871.39% increase from fiscal 2017.
- OCUGEN, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2017 was 322.12K shares, a 185.37% increase from fiscal 2016.
- OCUGEN, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2016 was 112.88K shares, a 35.93% decline from fiscal 2015.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 12 month |
|---|---|---|---|---|
| 2026-03-31 | 332.76K shares 10-Q · filed 2026-05-08 | |||
| 2025-12-31 | 1.26M shares 10-K · filed 2026-03-04 | |||
| 2025-03-31 | 80.44K shares 10-Q · filed 2025-05-09 | |||
| 2019-06-30 | 1.41M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | 2.95M shares 10-Q · filed 2019-08-09 | 6.04M shares derived: sum of 3 quarters · filed 2019-08-09 | 6.07M shares derived: sum of 4 quarters · filed 2019-08-09 |
| 2019-03-31 | 1.54M shares 10-Q · filed 2019-05-15 | 4.63M shares derived: sum of 2 quarters · filed 2019-05-15 | 4.66M shares derived: sum of 3 quarters · filed 2019-05-15 | 4.66M shares derived: sum of 4 quarters · filed 2019-05-15 |
| 2018-12-31 | 3.10M shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-22 | 3.13M shares derived: sum of 2 quarters · filed 2019-03-22 | 3.13M shares derived: sum of 3 quarters · filed 2019-03-22 | 3.13M shares 10-K · filed 2019-03-22 |
| 2018-09-30 | 30.77K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | 30.77K shares derived: sum of 2 quarters · filed 2018-11-08 | 32.00K shares 10-Q · filed 2018-11-08 | 119.23K shares derived: sum of 4 quarters · filed 2018-11-08 |
| 2018-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | 1.24K shares 10-Q · filed 2018-08-09 | 88.47K shares derived: sum of 3 quarters · filed 2018-08-09 | 272.12K shares derived: sum of 4 quarters · filed 2018-08-09 |
| 2018-03-31 | 1.24K shares 10-Q · filed 2018-05-10 | 88.47K shares derived: sum of 2 quarters · filed 2018-05-10 | 272.12K shares derived: sum of 3 quarters · filed 2018-05-10 | 294.13K shares derived: sum of 4 quarters · filed 2018-05-10 |
| 2017-12-31 | 87.23K shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | 270.88K shares derived: sum of 2 quarters · filed 2018-03-15 | 292.89K shares derived: sum of 3 quarters · filed 2018-03-15 | 322.12K shares 10-K · filed 2018-03-15 |
| 2017-09-30 | 183.65K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | 205.66K shares derived: sum of 2 quarters · filed 2017-11-09 | 234.89K shares 10-Q · filed 2017-11-09 | 236.34K shares derived: sum of 4 quarters · filed 2017-11-09 |
| 2017-06-30 | 22.01K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-10 | 51.24K shares 10-Q · filed 2017-08-10 | 52.69K shares derived: sum of 3 quarters · filed 2017-08-10 | 67.21K shares derived: sum of 4 quarters · filed 2017-08-10 |
| 2017-03-31 | 29.23K shares 10-Q · filed 2017-05-11 | 30.68K shares derived: sum of 2 quarters · filed 2017-05-11 | 45.20K shares derived: sum of 3 quarters · filed 2017-05-11 | 118.37K shares derived: sum of 4 quarters · filed 2017-05-11 |
| 2016-12-31 | 1.45K shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | 15.97K shares derived: sum of 2 quarters · filed 2017-03-16 | 89.14K shares derived: sum of 3 quarters · filed 2017-03-16 | 112.88K shares 10-K · filed 2017-03-16 |
| 2016-09-30 | 14.52K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | 87.69K shares derived: sum of 2 quarters · filed 2016-11-10 | 111.43K shares 10-Q · filed 2016-11-10 | 166.55K shares derived: sum of 4 quarters · filed 2016-11-10 |
| 2016-06-30 | 73.18K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-11 | 96.91K shares 10-Q · filed 2016-08-11 | 152.03K shares derived: sum of 3 quarters · filed 2016-08-11 | 161.79K shares derived: sum of 4 quarters · filed 2016-08-11 |
| 2016-03-31 | 23.73K shares 10-Q · filed 2016-05-12 | 78.86K shares derived: sum of 2 quarters · filed 2016-05-12 | 88.61K shares derived: sum of 3 quarters · filed 2016-05-12 | 107.18K shares derived: sum of 4 quarters · filed 2016-05-12 |
| 2015-12-31 | 55.12K shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-10 | 64.88K shares derived: sum of 2 quarters · filed 2016-03-10 | 83.45K shares derived: sum of 3 quarters · filed 2016-03-10 | 176.18K shares 10-K · filed 2016-03-10 |
| 2015-09-30 | 9.75K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | 28.32K shares derived: sum of 2 quarters · filed 2015-11-12 | 121.06K shares 10-Q · filed 2015-11-12 | |
| 2015-06-30 | 18.57K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-12 | 111.30K shares 10-Q · filed 2015-08-12 | ||
| 2015-03-31 | 92.73K shares 10-Q · filed 2015-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| Century Therapeutics, Inc. (IPSC) | United States | $0.306B | -4.02 |
| SAB Biotherapeutics, Inc. (SABS) | United States | $0.306B | -25.49 |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| X4 Pharmaceuticals, Inc (XFOR) | United States | $0.297B | -4.99 |
| Inhibikase Therapeutics, Inc. (IKT) | United States | $0.296B | -4.44 |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B |